RJFSA
NVIV

Raymond James Financial Services Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Raymond James Financial Services Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12
Closed -$123K – 2908
2018
Q1 		$123K Buy
12
+11
+1,100% +$123K ﹤0.01% 2351
2017
Q4 		$15K Hold
1
– – ﹤0.01% 2506
2017
Q3 		$39K Sell
1
-1
-50% -$30.7K ﹤0.01% 2471
2017
Q2 		$82K Hold
2
– – ﹤0.01% 2364
2017
Q1 		$147K Buy
+2
New +$162K ﹤0.01% 2209

Other funds holding NVIV

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial Services Advisors's NVIV Position: Q2 2018 in Review

Raymond James Financial Services Advisors sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2018, closing a stake of 12 shares — an estimated $123K sold.

Raymond James Financial Services Advisors first reported a position in NVIV in Q1 2017 and held it in 5 quarters. The position peaked at $147K in Q1 2017. 17 funds tracked by Wall St. Rank hold NVIV as of Q2 2018.

  • Raymond James Financial Services Advisors reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2018 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 12 InVivo Therapeutics Holdings Corp shares in Q2 2018, an estimated $123K.
  • Raymond James Financial Services Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q1 2017 and held it in 5 quarters.
  • Raymond James Financial Services Advisors's InVivo Therapeutics Holdings Corp position peaked at $147K in Q1 2017.
  • 17 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2018.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2018, filed 30 Jul 2018.